Welcome to our dedicated page for AlphaTON Capital news (Ticker: ATON), a resource for investors and traders seeking the latest updates and insights on AlphaTON Capital stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect AlphaTON Capital's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of AlphaTON Capital's position in the market.
AlphaTON Capital (Nasdaq: ATON) announced plans on Oct 29, 2025 to invest in enterprise GPU and data center infrastructure to support Cocoon, the Confidential Compute Open Network unveiled by Telegram founder Pavel Durov. AlphaTON said it will deploy next‑generation, high‑memory GPUs across strategic data centers to provide high uptime and capacity for private AI inference, supporting model architectures such as DeepSeek and Qwen. Telegram will be Cocoon's first major customer and the network is scheduled to launch in November 2025 after onboarding developers and GPU providers.
AlphaTON Capital (NASDAQ: ATON) announced that CEO Brittany Kaiser will be a featured speaker at the Future of Money, Governance, and the Law summit on Capitol Hill on October 30, 2025.
The summit, hosted by the Government Blockchain Association and The Edge Of Company, will convene policymakers, industry leaders, and innovators to discuss digital assets, governance, digital identity, tokenized ecosystems, and regulatory frameworks. Kaiser will speak on responsible innovation, digital identity, and how tokenized systems can empower individuals, reflecting AlphaTON’s focus on investments in early-stage blockchain and AI ventures that emphasize transparency and data sovereignty.
AlphaTON (Nasdaq: ATON) subsidiary Cyncado Therapeutics presented preclinical mesothelioma data showing selective A2B receptor inhibition produced direct anti-tumor effects across epithelial and non-epithelioid models. TT-4 monotherapy outperformed anti-PD-1 and TT-4 + anti-PD-1 achieved >90% tumor growth inhibition in vivo. Mechanistic readouts showed decreased pCREB and reduced tumor PD-L1. TT-4 is reported as IND-enabled and remains on track for first-patient dosing in Q1 2026. Cyncado will use these data to finalize clinical plans for mesothelioma.
AlphaTON Capital (Nasdaq: ATON) and Cyncado Therapeutics presented preclinical mesothelioma data on Oct 25, 2025 showing that selective A2B receptor antagonist TT-4 produced direct anti-tumor activity in epithelial and non-epithelial models, reduced pCREB and tumor PD-L1, modulated YAP signaling, and increased immune infiltration and tertiary lymphoid structures.
The poster reports TT-4 monotherapy exceeding anti-PD-1 in models and combination treatment further improving tumor control. The program is described as IND-enabled and on track for first-patient dosing in Q1 2026.
AlphaTON Capital (NASDAQ: ATON) appointed Wes Levitt as Chief Financial Officer, effective Oct 24, 2025. Levitt joins from Alpha Sigma Capital Advisors as former Co-CIO and previously served as Head of Strategy at Theta Labs and as CFO for a SPAC. He holds a B.S. in Economics and an MBA from Haas School of Business. At AlphaTON he will oversee finance, accounting, and capital markets operations and lead initiatives to optimize financial governance, scale investor communications, and support growth of the company’s global digital asset portfolio within the TON ecosystem.
AlphaTON Capital (Nasdaq: ATON) joined the Blockchain Game Alliance (BGA) on Oct 22, 2025 and expanded its Telegram/TON gaming strategy.
AlphaTON announced an intent to acquire a 51% equity stake in GAMEE, plus a planned token purchase, both subject to definitive documentation and approvals. The firm highlighted Telegram’s >1 billion monthly active users and the availability of TON Wallet to U.S. users as key distribution rails. AlphaTON will offer growth capital, launchpad/incubator support, go-to-market marketing, strategic partnerships, and a TON Gaming Builders track for BGA members to apply for funding and technical support.
AlphaTON Capital Corp (Nasdaq: ATON) and its oncology subsidiary Cyncado Therapeutics announced an AACR abstract (presented Oct 25, 2025) reporting that selective A2B (ADORA2B) receptor inhibition reduced adenosine-mediated PD-L1 expression in a human epithelioid mesothelioma cell line, linked to decreased pCREB. In an immunocompetent mesothelioma model, the investigational agent TT-4 as monotherapy outperformed anti-PD-1, and the TT-4 + anti-PD-1 combination showed significantly greater anti-tumor activity and increased T-cell infiltration. Additional data will be shown at the poster session in Boston on Saturday, October 25, 2025, 12:30–4:00 PM EDT.
AlphaTON Capital (NASDAQ: ATON) announced that Enzo Villani, Chief Investment Officer, will speak at the 10th Anniversary IASC World Changers Summit on October 20, 2025 at the Casina Pio IV in Vatican City.
Villani will deliver a 10-minute address on the intersection of ethics, innovation, and digital transformation, drawing on two decades of experience in finance, blockchain, and global impact. The Summit gathers global thought leaders to discuss ethical innovation, cooperation across nations and faiths, and sustainable, purpose-driven technology.
AlphaTON Capital (Nasdaq: ATON) sponsored and hosted the TOKEN2049 Singapore “Origins” Hackathon at Marina Bay Sands on October 15, 2025, awarding a US$25,000 prize pool paid in TON to global developers focused on AI, payments, and infrastructure.
Track leads and mentors selected winners across three tracks: AI (IntentHub 1st), Payments (Telepay 1st), and Infrastructure (Encrypted Prediction-Market Seeding 1st). AlphaTON said it will continue a global HackATON series to support TON builders with capital, mentorship, and go-to-market routes.
AlphaTON Capital (Nasdaq: ATON) CEO Brittany Kaiser will appear with Anthony Scaramucci on Schwab Network’s Trading 360 with Marley Kayden on October 14, 2025 at 11:30 a.m. ET. The live segment will discuss the evolving role of digital assets in modern finance and AlphaTON’s approach to funding cancer research using blockchain-based asset tokenization. The company describes tokenized assets as a way to connect investors and researchers and create new funding pathways. Viewers can watch the live discussion on Schwab Network.